Dangerous Drugs
Acetaminophen
Accutane
Alli
Avandia
Baycol
Bextra
Celexa
Celebrex
Cardura
Diclofenax (Cataflam and Voltaren)
Digitek
Enbrel
Ephedra
Fentanyl (Duragesic)
Fosamax
Gadolinium (MRI Injection)
Glyburide
Hydroxycut
Ketek
Lamisil
Lexapro
Lipitor
Lotronex
Lymerix
Methadone
Neurontin
OrthoEvra
Oxycontin
Quinine
Pain Pumps
Paxil
Phenylpropanolamine
Prempro
Propulsid
ReNu Recall
Rezulin
Rituxan
Stadol
Serevent and Advair
Synthroid
Tequin
Topamax
Topical Anesthetic
Trasylol (Aprotinin)
Vaccination Litigation (VICP)
Viagra
Vioxx
Vytorin
Yaz
Zicam
Zithromax (Azithromycin)
Zyban
Dangerous Drugs
Dangerous Drugs
Dangerous Drugs





 

Dangerous Drugs
 

Phenylpropanolamine

New York (NY) - Phenylpropanolamine Lawyer Helping Dangerous Drug Victims

The Food and Drug Administration (FDA) issued a public health advisory concerning phenylpropanolamine hydrochloride. This drug is widely used as a nasal decongestant (in over-the-counter and prescription drug products) and for weight control (in over-the-counter drug products). The FDA is taking steps to remove phenylpropanolamine from all drug products and has requested that all drug companies discontinue marketing products containing phenylpropanolamine.

Phenylpropanolamine has been marketed for many years. A recent study reported that taking phenylpropanolamine increases the risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is very low, FDA recommends that consumers not use any products that contain phenylpropanolamine.

FDA's Nonprescription Drugs Advisory Committee (NDAC) recently discussed this study and other information on phenylpropanolamine. NDAC determined that there is an association between phenylpropanolamine and hemorrhagic stroke and recommended that phenylpropanolamine not be considered safe for over-the-counter use.

Although this risk of hemorrhagic stroke is very low, FDA has significant concerns because of the seriousness of a stroke and the inability to predict who is at risk. FDA does not consider the conditions for which phenylpropanolamine is used (over-the-counter or by prescription) as justifying the risk of this serious event. Other products are available for use.

In the meantime, consumers can identify over-the-counter cough-cold, nasal decongestant, and weight control products containing this ingredient by looking for "phenylpropanolamine" in the list of active ingredients on the label. Consumers can check with their health care provider or pharmacist to see whether their prescription cough-cold or nasal decongestant product contains phenylpropanolamine. We advise consumers to discuss alternative over-the-counter and prescription products with their health care providers or pharmacists.

If you or loved one have been injured as a result of taking the above drug, you may have a valid claim. Call us now at 1-800-621-2020 or contact us.

Back To Dangerous Drugs

 
 
 
Melville Office
445 Broadhollow Road
Suite 205
Long Island, New York  11747
(800) 621-2020
Map & Directions
Garden City Office
1225 Franklin Avenue
Suite 325
Garden City, NY 11530
(800) 621-2020
Map & Directions

Buffalo Office:
2500 Main Place Tower
350 Main Street
Buffalo, New York 14202
(716) 854-2020
(800) 621-2020
Map & Directions

Rochester Office:
16 West Main Street
Powers Building, Suite 600
Rochester, New York 14614
(585) 454-2020
(800) 621-2020
Map & Directions

Grider Street Office:
451 Grider Street
Buffalo, New York 14215
(716) 854-2020
(800) 621-2020
Map & Directions

Manhattan Office:
405 Lexington Avenue
26th Floor, Chrysler Building
New York, New York  10174
(800) 621-2020
Maps & Directions